Which startups have raised the most funding in the mental health market?

Last updated: 7 September 2026

Download our beautiful pitch about the mental health market

market research pitch 2026 statistics mental health market

In our mental health market deck, you will find everything you need to understand the market

The mental health market has attracted billions of dollars across psychiatric drug development, virtual care, addiction treatment, digital therapeutics, behavioral health infrastructure, autism care and specialized clinical services.

To make this fragmented market easier to follow, we rank mental health startups by the cumulative amount of funding raised and update this list every month as new financing rounds are announced.

The ranking shows a highly concentrated market where a small group of heavily funded biotechnology and care-delivery companies sits above a long tail of specialized mental health startups.

And if you want to better understand this new industry, you can download our pitch covering the mental health market.

A quick summary table

Metric Value
Most funded mental health startup atai Life Sciences / AtaiBeckley, $872M
Second most funded mental health startup MindMed, $641M
Largest mental health funding round MindMed, $259M public offering in October 2025
Median mental health startup funding $56M
Share of mental health funding captured by the top 10 About 44%
Median time since last funding round About 32 months
Mental health startups funded in the last 12 months 19
Total mental health funding tracked About $8.34B
Mental health startups above $100M raised 29
Psychedelic and adjacent mental health funding About $2.29B across 13 selected companies
Chart illustrating yearly VC investment in mental health startups

This chart, featured in our mental health market deck, illustrates yearly VC investment in mental health startups

Top startups in the mental health market ranked by total funding raised

Here is an updated table that ranks the top startups in the mental health market based on the total amount of funding they have raised to date.

The table also includes the total number of funding rounds, the date and size of the latest round, the financing type (e.g. Series A, equity financing), key investors, the startup’s current status (active, IPO, acquired, or shut down), and a confidence score based on the data collected (we excluded startups with very low data confidence, to make sure everything is reliable).

If you're interested in knowing how much these startups are worth, you can check our list of the top startups in the mental health market ranked by valuation.

# Startup What They Do Total Raised ($) Total Rounds Last Round Date Last Round Amount ($) Last Round Type Key Investors Current Stage Confidence
1 atai Life Sciences / AtaiBeckley Novel psychiatric drug treatments $872M 8 October 2025 $150M Public Offering Berenberg, Ferring Ventures, Apeiron IPO Strong
2 MindMed Psychedelic-inspired psychiatric medicines $641M 10 October 2025 $259M Public Offering Jefferies, Leerink Partners, Evercore ISI IPO Strong
3 Cybin Psychedelic medicines for psychiatric disorders $454M 8 October 2025 $175M Registered Direct Offering Venrock, OrbiMed, Point72 IPO Partial
4 Akili Interactive Digital therapeutics for cognitive disorders $392M 5 August 2022 $162M PIPE Social Capital, Suvretta Capital, Apeiron Acquired Strong
5 Cortica Integrated autism and neurodevelopmental care $255M 7 November 2024 $80M Series E / Strategic Morgan Health, Nexus NeuroTech Ventures, Autism Impact Fund Active Partial
6 Alma Therapist insurance and practice platform $221M 5 August 2022 $130M Series D Thoma Bravo, Cigna Ventures, Insight Partners Active Full
7 Bright Minds Biosciences Serotonergic therapies for brain disorders $218M 6 January 2026 $175M Public Offering Jefferies, TD Securities, Piper Sandler IPO Strong
8 Cognito Therapeutics Noninvasive Alzheimer’s neurostimulation therapy $213M 3 March 2026 $105M Series C Morningside Ventures, IAG Capital Partners, Starbloom Capital Active Partial
9 Brightline Pediatric virtual behavioral healthcare $205M 5 July 2022 $10M Series C Extension Northwell Health Active Full
10 Draig Therapeutics Drugs for neuropsychiatric disorders $205M 3 July 2026 $65M Series B Deep Track Capital, Janus Henderson, Marshall Wace Active Strong
11 SonderMind Therapy marketplace and care platform $183M 4 July 2021 $150M Series C Drive Capital, Premji Invest, General Catalyst Active Strong
12 Click Therapeutics Prescription digital therapeutics platform $181M 7 April 2026 $50M Series D Boehringer Ingelheim Active Strong
13 Wayspring Value-based substance use disorder care $161M 7 May 2024 $45M Growth / Series D Extension CVS Health Ventures, Valtruis, .406 Ventures Active Strong
14 Delix Therapeutics Non-hallucinogenic neuroplasticity drugs $155M 3 August 2026 $85M Series C Johnson & Johnson Development Corporation Active Partial
15 Big Health Prescription digital mental health treatments $154M 6 February 2026 $24M Strategic / Growth .406 Ventures, AlleyCorp, CVS Health Ventures Active Strong
16 Lykos Therapeutics MDMA-assisted therapy for PTSD $150M 2 May 2025 $50M Series B Gracias Family Foundation, CH Foundation Active Strong
17 Pelago Digital substance use clinic $150M 5 March 2024 $58M Series C Atomico, Kinnevik, Eight Roads Ventures Active Full
18 Beckley Psytech Short-duration psychedelic psychiatric medicines $148M 5 January 2024 $40M Series C atai Life Sciences Acquired Strong
19 Workit Health Addiction treatment via telehealth $131M 4 October 2021 $118M Series C Insight Partners, CVS Health Ventures, FirstMark Capital Active Full
20 Eleos Health AI documentation for behavioral healthcare $128M 5 January 2025 $60M Series C Greenfield Partners, F-Prime Capital, Eight Roads Active Full
21 Eleanor Health Outpatient addiction and mental healthcare $115M 5 October 2024 $30M Series D General Catalyst, Town Hall Ventures, Echo Health Ventures Active Strong
22 Author Health Senior serious-mental-illness care $115M 1 June 2023 $115M Growth Equity General Atlantic, Flare Capital Partners Active Full
23 Brightside Health Virtual psychiatric care platform $114M 5 March 2024 $33M Series C S32, Kennedy Lewis, Time BioVentures Active Strong
24 Happify Health / Twill Digital behavioral health therapeutics platform $113M 6 March 2021 $73M Series D Deerfield Management, ION Crossover Partners, Omega Capital Acquired Partial
25 Woebot Health AI conversational mental health support $108M 3 March 2022 $10M Strategic Venture Leaps by Bayer Active Partial
26 Octave Outcomes-based mental healthcare network $106M 4 June 2023 $52M Series C Cigna Ventures, Novo Holdings, Avidity Partners Active Strong
27 Holmusk Behavioral health data analytics $106M 5 October 2023 $30M Series B Extension Veradigm, Health Catalyst Capital, Heritas Capital Active Partial
28 Two Chairs Technology-enabled therapy provider $104M 4 April 2024 $72M Series C Amplo, Fifth Down Capital Active Strong
29 Bicycle Health Virtual opioid addiction treatment $104M 5 January 2025 $17M Series C / Venture Questa Capital, SignalFire, Frist Cressey Ventures Active Strong
30 InStride Health Pediatric anxiety and OCD treatment $86M 3 June 2026 $30M Series C Echo Health Ventures, FMZ Ventures, .406 Ventures Active Strong
31 Boulder Care Virtual addiction treatment and recovery $85M 4 May 2024 $35M Series C Advance Venture Partners, First Round Capital, Qiming Venture Partners USA Active Full
32 NOCD OCD-focused virtual therapy $84M 4 January 2023 $34M Series C 7wire Ventures, Cigna Ventures, Eight Roads Ventures Active Strong
33 Valera Health Virtual high-acuity behavioral healthcare $79M 7 April 2024 $9M Equity Financing Undisclosed Acquired Partial
34 ieso AI-powered digital therapy $78M 3 November 2021 $53M Series B Morningside, Sony Innovation Fund, IP Group Acquired Strong
35 Tava Health Virtual behavioral healthcare platform $73M 4 April 2026 $40M Series C Centana Growth Partners, Catalyst Investors, Peterson Ventures Active Full
36 Gilgamesh Pharmaceuticals Novel neuropsychiatric psychedelic drugs $68M 4 December 2022 $39M Series B Prime Movers Lab, Satori Capital, Alumni Ventures Acquired Strong
37 Ophelia Online opioid addiction treatment $68M 3 December 2021 $50M Series B Tiger Global, Menlo Ventures, General Catalyst Active Full
38 aptihealth Higher-acuity behavioral healthcare $61M 3 April 2023 $11M Series B Extension H/L Ventures, Takeda Digital Ventures Active Strong
39 Numinus Psychedelic mental-health services and research $59M 6 February 2024 $4M Public Offering Eight Capital, Stifel GMP, Integrated V.C. IPO Strong
40 Cartwheel Care School-based pediatric mental healthcare $59M 4 February 2026 Undisclosed Venture BakerBridge Capital Active Strong
41 NeuroFlow Behavioral health workflow software $58M 5 October 2022 $25M Series C SEMCAP, Alumni Ventures Active Partial
42 Osmind Mental health practice software $57M 4 May 2022 $40M Series B DFJ Growth, General Catalyst, Tiger Global Active Full
43 Concert Health Primary-care behavioral health integration $56M 3 April 2022 $42M Series B Define Ventures, Healthy Ventures, CommonSpirit Health Active Strong
44 Forta AI-enabled autism therapy $56M 2 January 2024 $55M Series A Insight Partners, Exor Ventures, Alumni Ventures Active Strong
45 Meru Health Digital mental health clinic $55M 5 September 2021 $30M Series B Industry Ventures, Bold Capital Partners, Freestyle Capital Active Strong
46 AnswersNow Virtual ABA autism therapy $54M 5 January 2026 $40M Series B HealthQuest Capital, Left Lane Capital, Owl Ventures Active Strong
47 firsthand Peer-led serious mental illness care $53M 3 July 2026 $10M Series B Extension GV Active Strong
48 Freespira Digital panic and PTSD therapy $51M 7 April 2024 $23M Series E Undisclosed investors Active Partial
49 Mindbloom At-home clinician-guided ketamine therapy $50M 3 2021 $35M Series B Kleiner Perkins, Quiet Capital, FundersClub Active Full
50 Affect Therapeutics Digital substance-use and mental healthcare $49M 5 September 2025 $26M Series B Allumia Ventures, ARTIS Ventures, City Light Capital Active Partial
51 Small Pharma DMT therapies for depression $47M 2 April 2021 $46M RTO Equity Financing Brokered institutional investors Acquired Strong
52 Amae Health Integrated severe mental illness clinics $46M 5 November 2025 $25M Series B Altos Ventures, 8VC, Quiet Capital Active Partial
53 Iris Telehealth Telepsychiatry provider network $43M 2 April 2022 $40M Series B Concord Health Partners, Columbia Pacific Advisors Active Full
54 Uwill Student mental health platform $39M 3 May 2023 $30M Series A Education Growth Partners Active Strong
55 Little Otter Family mental health care $36M 3 February 2025 $10M Strategic Equity Pivotal Ventures, Torch Capital, Springbank Active Partial
56 Array Behavioral Care Virtual psychiatric care provider $32M 4 January 2023 $25M Series C CVS Health Ventures, Wells Fargo Strategic Capital, Health Velocity Capital Acquired Strong
57 Bend Health Virtual pediatric behavioral health care $32M 2 March 2023 $27M Series A Maveron, WVV Capital, SteelSky Ventures Acquired Full
58 HelloSelf Online therapy and psychological coaching $31M 3 March 2023 $20M Series B Octopus Ventures, OMERS Ventures, Manta Ray Ventures Active Strong
59 Mantra Health Student mental health services $31M 3 March 2023 $5M Series A Extension VMG Partners, Alumni Ventures, Global Founders Capital Active Strong
60 PursueCare Virtual addiction and mental healthcare $31M 4 December 2023 $20M Series B T.Rx Capital, Yamaha Motor Ventures, OCA Ventures Active Partial
61 SpectrumAi Autism-care analytics and software $29M 2 March 2023 $20M Series A CVS Health Ventures, Cobalt Ventures, F-Prime Capital Active Full
62 Healios Digital youth mental healthcare $29M 3 November 2022 $16M Series B Claret Capital Partners, AlbionVC, Autism Impact Fund Active Strong
63 OxfordVR Automated VR psychological therapy $27M 3 July 2021 $10M Series A Extension Oxford Science Enterprises, Optum Ventures Acquired Partial
64 Nue Life Health At-home ketamine-assisted mental-health care $26M 3 June 2023 Undisclosed Venture Round Obvious Ventures, Magic VC, Palm Drive Capital Acquired Partial
65 Marigold Health Peer mental health recovery support $26M 6 February 2026 $0M Convertible Note Rock Health Capital Active Partial
66 Ria Health Online alcohol use disorder treatment $25M 4 February 2025 $7M Series B Peloton Equity, SV Health Investors, BPEA Private Equity Active Partial
67 Blackbird Health Precision youth mental healthcare $23M 2 February 2024 $17M Series A Define Ventures, Frist Cressey Ventures, GreyMatter Active Partial
68 Opya Early-intervention autism therapy $22M 3 August 2021 $15M Series A Panoramic Ventures, SB Opportunity Fund, Disability Opportunity Fund Active Partial
69 BehaVR VR behavioral-health digital therapeutics $21M 3 December 2022 $13M Series B Optum Ventures, Oxford Science Enterprises, Confluent Health Acquired Strong
70 Brave Health Medicaid virtual behavioral healthcare $21M 2 October 2021 $10M Series B City Light Capital, Union Square Ventures, Able Partners Active Strong
71 Birches Health Addiction care platform $20M 2 September 2025 Undisclosed Series A AlleyCorp, Will Ventures, defy.vc Active Partial
72 Backpack Healthcare Medicaid-focused pediatric mental healthcare $19M 4 September 2025 $3M Series A Extension G2 Venture Partners, PACE Healthcare Capital Active Strong
73 Monument Online alcohol treatment platform $18M 2 January 2021 $10M Series A VMG Catalyst, Lerer Hippeau, Collaborative Fund Active Full
74 Braxia Scientific Ketamine clinics and psychedelic research $17M 6 February 2023 $1M LIFE / Private Placement Roger McIntyre, public investors Shutdown Partial
75 GrayMatters Health Brain-biomarker mental health therapeutics $16M 3 March 2023 $2M SAFE / Equity EIC Fund Active Strong
76 Fort Health Integrated pediatric behavioral healthcare $14M 2 November 2024 $6M Seed II Twelve Below, Vanterra Capital, Blue Venture Fund Active Partial
77 Psylo Non-hallucinogenic neuroplastogen medicines $14M 3 June 2024 $8M Series Seed Palo Santo, Focalpoint Ventures, Tenmile Active Full
78 Awakn Life Sciences Addiction and mental-health drug development $12M 4 June 2024 $1M Private Placement Undisclosed investors Acquired Partial
79 Journey Clinical Therapist-led ketamine-assisted psychotherapy $12M 4 January 2023 $9M Series A Union Square Ventures, Fifty Years, AlleyCorp Active Strong
80 Manatee Virtual therapy for families $12M 4 June 2024 $5M Series A Extension Grand Ventures, GreyMatter Capital Active Partial
81 Flow Neuroscience At-home depression brain stimulation $12M 3 August 2021 $9M Series A Khosla Ventures, SwissHealth Ventures, Zühlke Ventures Active Strong
82 Psyomics AI mental-health assessment technology $11M 6 June 2024 $5M Venture / Growth Equity Parkwalk Advisors Active Partial
83 Sonara Health Remote methadone adherence care platform $6M 3 August 2025 $1M Venture / Strategic Boomerang Ventures, Acumen America, Sorenson Impact Foundation Active Partial
84 DynamiCare Health Digital addiction recovery and incentives $6M 4 March 2025 Undisclosed Venture Round Halcyon Venture Partners, Hyperplane Venture Capital Active Partial
85 Clerkenwell Health Psychedelic clinical research organization $3M 2 October 2022 $2M Seed Lionheart Ventures, Convergence Partners, Exceptional Ventures Active Strong
86 Innerwell Ketamine therapy with psychotherapy $3M 1 May 2022 $3M Pre-Seed Greycroft, Looking Glass Capital, Max Ventures Active Full
Market map chart showing top companies and startups in the mental health market

This market map, featured in our mental health market deck, highlights top companies and startups in the mental health market

Key funding trends in the mental health market

Insights

  • Mental health startup funding is highly concentrated. The ten largest companies account for about $3.68B, or roughly 44% of the $8.34B tracked across the ranking.
  • Psychedelic and psychedelic-adjacent mental health companies account for approximately $2.29B across 13 selected businesses, showing how capital-intensive psychiatric drug development has become compared with most care-delivery models.
  • Addiction-focused mental health platforms such as Wayspring, Pelago, Workit Health, Eleanor Health, Bicycle Health, Boulder Care and Ophelia have collectively raised more than $800M, making substance-use care a major venture-backed segment.
  • Digital therapeutics companies including Akili, Big Health, Click Therapeutics, Osmind, BehaVR and Flow Neuroscience raised more than $800M, yet their outcomes range from continued independence to acquisition.
  • Pediatric and youth mental health startups including Brightline, InStride Health, AnswersNow, Bend Health, Healios, Backpack Healthcare and SpectrumAi collectively raised about $453M, creating a meaningful specialized funding category.
  • Investor interest extends beyond consumer therapy apps. Eleos Health, Concert Health, Alma and Wayspring raised more than $560M while building infrastructure connected to providers, insurers and healthcare workflows.
  • Some mental health startups have unusually concentrated capitalization. Author Health raised its entire $115M total in one financing, while Forta’s $55M Series A represents almost all of its $56M cumulative funding.
  • The mental health market has a clear financing split. Psychiatric biotechnology companies often require very large rounds, while many virtual care, therapy and specialty-clinic businesses have built meaningful platforms with less than $100M.
Google Trends chart showing rising interest in men’s mental health

As this chart shows, and as featured in our mental health market deck, search interest in men’s mental health has been rising steadily

A few word about our methodology

As you can see, we built a database that ranks startups in the mental health market based on their total cumulative fundraising. To create this ranking, we reviewed many sources and cross-checked information across multiple places.

Whenever possible, we prioritized official company communications, since they are the most reliable source for funding amounts. When those were not available, we relied on reputable industry sources such as TechCrunch, Crunchbase, Financial Times or Forbes (to name a few).

We excluded random blogs, unverified websites, and any sources that could not be validated.

We focused on financing that represents capital raised by mental health companies, while excluding acquisition consideration and other transactions that do not represent new primary capital when these could be identified.

When funding rounds were announced in other currencies such as euros, Swiss francs, Singapore dollars, Australian dollars, or rupees, we converted them into approximate USD equivalents for consistency.

Sometimes different sources report slightly different numbers, or the exact round size is not fully disclosed. In those cases, we flag the uncertainty and assign a confidence label to each startup, visible in the last column.

Here is what they mean.

Full confidence: The company’s equity fundraising history can be reconstructed completely from public sources. The rounds, dates, amounts, and key investors are clearly identified, with no meaningful gaps.

Strong confidence: The fundraising history is largely complete and reliable. There may be a small missing detail, such as incomplete investor information or a minor round with limited data, but the overall record is clear.

Partial confidence: The main fundraising rounds can be identified, but the record is incomplete or somewhat mixed. Some rounds may be missing or certain funding events may be difficult to separate clearly.

Low confidence: Public information is too limited, inconsistent, or ambiguous to reliably reconstruct the company’s equity fundraising history.

When the confidence level is too low, we take a conservative approach and exclude the company from the ranking. We don’t want to include data that cannot be reliably verified.

This reflects how we conduct all our research, including the work behind our report covering the mental health market.

In a world where LLMs hallucinate and unreliable information is everywhere, our goal is simple: provide data you can trust.

If you want the full detail on a specific calculation, feel free to contact us and we will gladly explain.

Finally, know that we update the dataset once per month, so come back here if you need fresh information.

Chart showing why Talkspace is winning in the mental health market

This chart, featured in our mental health market deck, shows why Talkspace is winning in mental health

Who is the author of this content?

NEW MARKET PITCH TEAM

We track new markets so founders and investors can move faster

We build living “market pitch” documents for emerging markets: from AI to synthetic biology and new proteins. Instead of digging through outdated PDFs, random blog posts, and hallucinated LLM answers, our clients get a clean, visual, always-updated view of what’s really happening. We map the key players, deals, regulations, metrics and signals that matter so you can decide faster whether a market is worth your time. Want to know more? Check out our about page. You can also follow us on Instagram or on Facebook.

How we created this content 🔎📝

At New Market Pitch, we kept seeing the same problem: when you look at a new market, the data is either missing, paywalled, or buried in 300-page reports that feel like they were written in the 80s. On the other side, LLMs and random blog posts give you confident answers with no sources, and sometimes they just make things up. That’s not good enough when you’re about to invest real money or launch a company.

So we decided to fix the experience. For each market we cover, we build a structured database and update it on a regular basis. We track funding rounds, fund memos, M&A moves, partnerships, new products, policy changes, and the real activity of startups and incumbents. Then we turn all of that into a clear “market pitch” that shows where the opportunities are and how people actually win in that space.

Every key data point is checked, sourced, and put back into context by our team. That’s how we can give you both speed and reliability: fast coverage of new markets, without the usual guesswork.

Back to blog